肿瘤微环境异质性的研究进展

doi:10.11904/j.issn.1002-3070.2017.03.014

摘要/Abstract

摘要： 在肿瘤发生及发展过程中,肿瘤微环境起着至关重要的作用。已有研究证实肿瘤微环境异质性对肿瘤的疗效及耐药性有着巨大影响。本文综述了肿瘤微环境中免疫细胞及相关的免疫因子,以及血管内皮细胞异质性与肿瘤进展及预后的关系。从而更好的帮助我们理解肿瘤微环境异质性对于肿瘤的影响。有利于我们通过多种手段增强机体的抗肿瘤能力,从而抑制和杀伤肿瘤细胞。

关键词: 肿瘤微环境, 异质性, 免疫

Abstract: The tumor microenvironment plays a vital role in the process of tumorigenesis and development.Studies have been confirmed that the tumor microenvironment heterogeneity has a huge impact on the tumor efficacy and drug resistance.This review summarizes the relationship between immune cells and related immune factors in tumor microenvironment as well as vascular endothelial cell heterogeneity and tumor progression and prognosis.So it is better help us understand the tumor microenvironment heterogeneity for the impact of the tumor.This will conduce to us through a variety of methods to enhance the body′s anti-tumor ability by inhibiting and killing tumor cells.

Key words: Tumor microenvironment, Heterogeneity, Immune

中图分类号:

徐洋，秦琪，赵红，刘健鸿综述，张清媛审校. 肿瘤微环境异质性的研究进展[J]. 实用肿瘤学杂志, 2017, 31(3): 258-261.

XU Yang,QIN Qi,ZHAO Hong,LIU Jianhong,ZHANG Qingyuan. Research progress of tumor microenvironment heterogeneity[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 258-261.

参考文献

1 Kothari AN,Mi Z,Zapf M,et al.Novel clinical therapeutics targeting the epithelial to mesenchymal transition[J].Clin Transl Med,2014,3(1):35-49.
2 Thomas PD,Kahn M.Kat3 coactivators in somatic stem cells and cancer stem cells:biological roles,evolution,and pharmacologic manipulation[J].Cell Biol Toxicol,2016,32(1):61-81.
3 Zhang D,Chen Z,Wang DC,et al.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer[J].Cancer Metastasis Rev,2015,34(2):277-290.
4 Shi L,Wang L,Hou J,et al.Targeting roles of inflammatory microenvironment in lung cancer and metastasis[J].Cancer Metastasis Rev,2015,34(2):319-331.
5 Yang D,Zhou J,Zeng T,et al.Serum chemokine network correlates with chemotherapy in non-small cell lung cancer[J].Cancer Lett,2015,365(1):57-67.
6 Nemenoff R.Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis[J].PLos One,2011,6(12):403-404.
7 Phillips JD,Knab LM,Blatner NR,et al.Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer[J].Cancer Immunol Immunother,2015,64(9);1185-1191.
8 Huang P,Xu X,Wang L,et al.The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment[J].J Cell Mol Med,2014,18(2):218-230.
9 Janols H,Bergenfelz C,Allaoui R,et al.A high frequency of MDSCs in sepsis patients,with the granulocytic subtype dominating in gram-positive cases[J].J Leukoc Biol,2014,96(5):685-693.
10 Zhang B,Wang Z,Wu L,et al.Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma[J].PLoS One,2013,8(2):e57114.
11 Ortiz ML,Lu L,Ramachandran I,et al.Myeloid-derived suppressor cells in the development of lung cancer[J].Cancer Immunol Res,2014,2(1):50-58.
12 Hasegawa T,Suzuki H,Yamaura T,et al.Prognostic value of peripheral and local forkhead box P3(+)regulatory T cells in patients with non-small-cell lung cancer[J].Mol Clin Oncol,2014,2(5):685-694.
13 Goc J,Germain C,Vobourgais TKD,et al.Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+T cells[J].Cancer Res,2014,74(3):705-715.
14 Fridman WH,Galon J,Dieu-Nosjean MC,et al.Immune infiltration in human cancer:prognostic significance and disease control[J].Curr Top Microbiol Immunol,2011,344(1):1-24.
15 Huang S,Fang R,XU J,et al.Evaluation of the tumor targeting a FAP-α based doxorubicin prodrug[J].Drug Target,2011,19(7):487-496.
16 Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
17 Lippitz BE.Cytokine patterns in patients with cancer:a systematic review[J].Lancet Oncol,2013,14(6):218-228.
18 Houghton AM,Rzymkiewicz DM,Ji H,et al.Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth[J].Nat Med,2010,16(2):219-223.
19 Katerina A,Denis ITI,Raphaela S,et al.Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma[J].Br J Cancer,2015,113(6):902-913.
20 Choi H,Sheng J,Gao D,et al.Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model[J].Cell Rep,2015,10(7):1187-1201.
21 Shimizu.K,Okita.R,Nakata.M.Clinical significance of the tumor microenvironment in non-small cell lung cancer[J].Ann Transl Med,2013,1(2):20-23.
22 Nagaraj S,Gabrilovich DI.Myeloid-derived suppressor cells in human cancer[J].Cancer J,2010,16(4):348-353.
23 Yang L,Huang J,Ren X,et al.Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis [J].Cancer Cell,2008,13(1):23-35.
24 Wang L,Yi T,Kortylewski M,et al.IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway[J].J Exp Med,2009,206(7):1457-1464.
25 Grivennikov SI,Greten FR,Karin M.Immunity,inflammation,and cancer[J].Cell,2010,140(6):883-899.
26 Krausgruber T,Blazek K,Smallie T,et al.IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses [J].Nat Immunol,2011,12(3):231-238.
27 Gardner JC,Noel JG,Nikolaidis NM,et al.G-CSF drives a posttraumatic immune program that protects the host from infection[J].J Immunol,2014,192(5):2405-2417.
28 Ding G,Niu J,Li Y.Dental pulp stem cells suppress the proliferation of lymphocytes via transforming growth factor-β1[J].Hum Cell,2015,28(2):81-90.
29 Rafii S,Avecilla ST,Jin DK.Tumor vasculature address book:identification of stage-specific tumor vessel zip codes by phage display[J].Cancer Cell,2003,4(5):331-333.
30 Junttila MR,De Sauvage FJ.Influence of tumour micro-environment heterogeneity on therapeutic response[J].Nature,2013,501(7467):346-354.

[1]	赵苏, 郑晓瑜, 朱开彬, 卜建龙, 徐世东. 肺癌完全性切除术对患者外周血中Th17/Treg细胞平衡的影响[J]. 实用肿瘤学杂志, 2019, 33(2): 142-148.
[2]	刘恒辰, 张新宇. Toll样受体信号通路作为结直肠癌潜在治疗靶点的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 188-192.
[3]	付艳丽, 余杨, 卫玮, 邹晶晶, 孙翔. 高危型人乳头状瘤病毒载量和Th1/Th2不均衡表达预测宫颈癌变进程的研究[J]. 实用肿瘤学杂志, 2018, 32(6): 533-537.
[4]	何煦, 叶尚勉, 董丹丹, 李科. HLA-G在乳腺癌中的表达及意义[J]. 实用肿瘤学杂志, 2018, 32(5): 410-414.
[5]	李悦, 徐可, 韩增祥, 孙敏, 樊国华综述, 张勇审校. 结肠癌中肿瘤相关巨噬细胞的作用及靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 450-454.
[6]	崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.
[7]	孙祖刚, 王哲, 陈怀安, 刘硕, 苗文隆. 诱发膀胱癌的常见慢性炎症因素及其免疫治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(4): 357-361.
[8]	张婷, 贾迪(综述), 杨丹(审校). 骨肉瘤的生物学治疗进展[J]. 实用肿瘤学杂志, 2018, 32(3): 254-257.
[9]	吕强, 陈洪生, 李国东, 魏九峰(综述), 刘明(审校). 肿瘤相关成纤维细胞在大肠癌发生发展中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(3): 275-279.
[10]	马超(综述), 王国年(审校). 麻醉药物对围术期癌症患者免疫功能的影响[J]. 实用肿瘤学杂志, 2018, 32(3): 285-288.
[11]	张培, 曹守波, 于雁. 自噬介导的肿瘤相关巨噬细胞调控机制的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 130-134.
[12]	雷婉婷, 王静萱. 肿瘤微环境在肿瘤细胞有氧糖酵解中的作用[J]. 实用肿瘤学杂志, 2018, 32(2): 189-192.
[13]	王庆辉, 孙悦, 姜万维. 探讨氟比洛芬酯应用于宫颈癌手术术后镇痛的临床效果[J]. 实用肿瘤学杂志, 2018, 32(1): 33-37.
[14]	苗素平, 郭二亮, 裴荣, 姜寰宇, 苗素生. miRNA调节免疫检查点在肿瘤治疗中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(1): 57-62.
[15]	申美莹, 庞达. 长链非编码RNA在肿瘤微环境中的调控作用[J]. 实用肿瘤学杂志, 2018, 32(1): 73-76.